Dr Emma Law, narrating her blog written for the Dementia Researcher website.

Clinical trials in dementia rely on carefully designed safeguards to protect participants and ensure treatments are tested responsibly. Emma Law explains how safety is built into every stage of a trial, from ethical recruitment and consent to screening processes, monitoring, and staff training. In this blog Emma highlights how lessons from past trial failures shaped current best practice and emphasises the shared responsibility between researchers, participants, carers, and sponsors to ensure studies run safely while advancing new treatments.

Find the original text, and narration here on our website.

https://www.dementiaresearcher.nihr.ac.uk/blog-how-we-ensure-safety-in-dementia-drug-trials/

#DementiaResearch #ClinicalTrials #Research #TrialDelivery

Dr Emma Law is Strategic Manager for the The Neuroprogressive and Dementia Network in Scotland. Emma has 13 years experience as a Clinical Trails Network Manager and over 35 years experience as a Nurse, many of which were spent in the delivery of Clinical Research Trials. Emma completed her PhD and is passionate about giving people living with dementia and their carers access to participate in research.

Enjoy listening? We're always looking for new bloggers, drop us a line. http://www.dementiaresearcher.nihr.ac.uk

This podcast is brought to you in association with Alzheimer's Association, Alzheimer's Research UK, Alzheimer's Society and Race Against Dementia, who we thank for their ongoing support.

Join our community:

https://onelink.to/dementiaresearcher

Dr Emma Law - How We Ensure Safety in Dementia Drug Trials

Powered by Wave AI